Form 4: BIO-TECHNE Executive Reports Stock Transaction
Insider Transaction (Form 4)
Shane Bohnen, SVP - General Counsel of BIO-TECHNE Corp, reported multiple transactions in common stock on August 15, 2026.
Summary
- Option exercise/conversion: acquired 4,350 Common Stock on August 15, 2026; holds 11,703 after (Direct).
- Tax/exercise-price withholding: disposed of 1,343 Common Stock at $72.40 ($97,233) on August 15, 2026; holds 10,360 after (Direct).
- Option exercise/conversion: disposed of 49 Restricted Stock Units on August 15, 2026 (Direct).
- Disposition to the issuer: disposed of 12,117 Performance Stock Option (Right to Buy) on August 15, 2026; holds 807 after (Direct).
- Option exercise/conversion: disposed of 300 Performance Restricted Stock Units on August 15, 2026; holds 4,502 after (Direct).
- Disposition to the issuer: disposed of 4,502 Performance Restricted Stock Units on August 15, 2026 (Direct).
- Option exercise/conversion: disposed of 1,669 Restricted Stock Units on August 15, 2026; holds 1,669 after (Direct).
- Option exercise/conversion: disposed of 2,332 Restricted Stock Units on August 15, 2026; holds 4,664 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Shane Bohnen — Officer (SVP - General Counsel)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-15 | Option exercise/conversion | Common Stock | 4,350 | — | — | 11,703 |
| 2026-08-15 | Tax/exercise-price withholding | Common Stock | 1,343 | $72 | $97.2K | 10,360 |
| 2026-08-15 | Option exercise/conversion | Restricted Stock Units | 49 | — | — | 0 |
| 2026-08-15 | Disposition to the issuer | Performance Stock Option (Right to Buy) | 12,117 | — | — | 807 |
| 2026-08-15 | Option exercise/conversion | Performance Restricted Stock Units | 300 | — | — | 4,502 |
| 2026-08-15 | Disposition to the issuer | Performance Restricted Stock Units | 4,502 | — | — | 0 |
| 2026-08-15 | Option exercise/conversion | Restricted Stock Units | 1,669 | — | — | 1,669 |
| 2026-08-15 | Option exercise/conversion | Restricted Stock Units | 2,332 | — | — | 4,664 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-15 | Option exercise/conversion (4,350 shares) |
| 2026-08-15 | Tax/exercise-price withholding (1,343 shares) |
| 2026-08-15 | Option exercise/conversion (49 shares) |
| 2026-08-15 | Disposition to the issuer (12,117 shares) |
| 2026-08-15 | Option exercise/conversion (300 shares) |
| 2026-08-15 | Disposition to the issuer (4,502 shares) |
| 2026-08-15 | Option exercise/conversion (1,669 shares) |
| 2026-08-15 | Option exercise/conversion (2,332 shares) |
Keywords
insider transaction, Form 4, TECH, BIO-TECHNE Corp, neutral, Shane Bohnen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.